Elizabeth Faust
Director/Board Member at BIOMEA FUSION, INC.
Net worth: - $ as of 2024-03-30
Network origin in Elizabeth Faust first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 32 | |
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Unknown | 19 | ||
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA
4
| Extinct | Pharmaceuticals: Major | 4 |
| Public Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Elizabeth Faust via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Administrative Officer Director of Finance/CFO Private Equity Investor Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal General Counsel Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO General Counsel Compliance Officer Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Founder Founder Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Director/Board Member Founder General Counsel | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Founder Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Founder Consultant / Advisor Founder | |
| SUMMIT THERAPEUTICS INC. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| PULSE BIOSCIENCES, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Director/Board Member Consultant / Advisor Director/Board Member Director/Board Member | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman Consultant / Advisor Private Equity Investor | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Founder Founder Director/Board Member Founder | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Director/Board Member Chairman | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman Director/Board Member | |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Operating Officer Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Robert W. Duggan & Associates
 Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Investment Managers | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member | |
Kite Pharma UK Ltd.
 Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The private company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| The California State University | College/University | Undergraduate Degree Undergraduate Degree | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member | |
105 W First Street LLC
 105 W First Street LLC Real Estate Investment TrustsFinance 105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder Director/Board Member | |
| Golden Gate University | College/University | Masters Business Admin Masters Business Admin | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Sofie Biosciences, Inc.
 Sofie Biosciences, Inc. Medical SpecialtiesHealth Technology Sofie Biosciences, Inc. operates as a diagnostics company that provides molecular imaging probes and devices to help scientists and physicians investigate the biology of disease. It combines the discovery and development of new PET imaging probes with innovative imaging systems and chemistry platforms to provide researchers and physicians with tools to better understand the biology of disease. The company was founded by Owen N. Witte, Michael E. Phelps, Jim Heath, Johannes Czernin, and Caius Radu in 2008 and is headquartered in Culver City, CA. | Medical Specialties | Director/Board Member Founder |
Statistics
International
| United States | 46 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 28 |
| Finance | 10 |
| Consumer Services | 8 |
| Commercial Services | 6 |
Operational
| Director/Board Member | 510 |
| Corporate Officer/Principal | 214 |
| Independent Dir/Board Member | 140 |
| Chairman | 81 |
| Founder | 66 |
Most connected contacts
| Insiders | |
|---|---|
| David Bonderman | 89 |
| Franz Humer | 45 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Ran Nussbaum | 38 |
| Ian Clark | 35 |
| Robin Washington | 34 |
| Helen Kim | 33 |
| Bihua Chen | 32 |
| Eric Aguiar | 29 |
| Lori Kunkel | 27 |
| Alan Colowick | 27 |
| David Tanen | 25 |
| Thomas Dyrberg | 24 |
| Shawn Tomasello | 22 |
- Stock Market
- Insiders
- Elizabeth Faust
- Company connections
